Prevalence of diabetes and frequency of glycated haemoglobin monitoring in Extremadura (Spain) during 2012, 2013 and 2014: An observational study.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 30630669.
- Also identified by DOI 10.1016/j.pcd.2018.12.006.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To analyze the prevalence of diabetes and the frequency of haemoglobin A<sub>1C</sub> (HbA<sub>1C</sub>) monitoring in the population with diabetes in Extremadura (Spain). Observational, longitudinal retrospective study in the population attended in the Extremadura Health System in 2012-2014. A total of 403,644 glycated haemoglobin determinations in 189,466 subjects (52.4% female) were studied. All patients with a prescription of antidiabetic drugs and those who, despite not having treatment, had any determination of HbA<sub>1C</sub> ≥6.5% were considered as people with diabetes. All patients without treatment but with HbA<sub>1C</sub> ≥5.7% and <6.5% were considered prediabetes patients. The prevalence rate of diabetes was 8.3% and the frequency of HbA<sub>1C</sub> monitoring was 0.9/patient/year in the diabetic population. 48.2% of the patients with monitoring of HbA<sub>1C</sub> had diabetes, 21.2% had prediabetes, and 30.6% did not meet the criteria for diabetes or prediabetes. 12.7% of people with diabetes did not have determinations of HbA<sub>1C</sub> and only 11.8% have had ≥6 determinations in the period analyzed. The frequency of HbA<sub>1C</sub> monitoring in the diabetic population is lower than that usually recommended. Moreover, there is an inadequate use of HbA<sub>1C</sub> determinations, since one out of every 3 patients does not meet the criteria for diabetes or prediabetes.
Medical subject headings
- Diabetes Mellitus
- Glycated Hemoglobin
- Practice Patterns, Physicians'